Industry News

Pharmaceutical Industry News

Novo CEO Mike Doustdar—tapped to…

September 16th, 2026|Fierce Pharma|

Novo CEO Mike Doustdar—tapped to breathe new life into the Danish drugmaker last year after losing GLP-1 marketing ground to chief rival Eli Lilly—isn’t one to make changes for the sake of change.

After a 2024 rebuff, AstraZeneca…

September 16th, 2026|Fierce Pharma|

After a 2024 rebuff, AstraZeneca and Daiichi Sankyo’s star antibody drug conjugate Enhertu has been deemed cost effective for NHS use in HER2-low advanced breast cancer by England and Wales' drug value assessor.

New phase 3 data show Vera…

September 16th, 2026|Fierce Pharma|

New phase 3 data show Vera Therapeutics’ Trutakna successfully stabilizes kidney function in IgA nephropathy patients, mirroring an earlier clinical success from Otsuka’s Voyxact and heating up competition in a rapidly evolving market race.

Cellares is partnering with…

September 16th, 2026|Fierce Pharma|

Cellares is partnering with Taiwanese biotech GenomeFrontier Therapeutics to evaluate the integrated contract developer and manufacturer’s cell shuttle platform for use in the production of virus-free CAR-T therapies.

As Amgen advances its bid to join…

September 16th, 2026|Fierce Pharma|

As Amgen advances its bid to join the first wave of biosimilars to Bristol Myer Squibb and Ono’s oncology megablockbuster Opdivo, the originator drug’s partners are not taking the challenge lying down.

The health and hygiene…

September 16th, 2026|Fierce Pharma|

The health and hygiene conglomerate, known for brands like Lysol and Mucinex, will spend the funds building out an R&D hub at its new headquarters and finalizing the largest of its seven manufacturing sites by

Legend Biotech has found its…

September 16th, 2026|Fierce Pharma|

Legend Biotech has found its permanent CEO, poaching 15-year Novartis veteran Ingrid Zhang as the CAR-T specialist eyes its next phase of growth.

The rare disease biotech announced…

September 15th, 2026|Fierce Pharma|

The rare disease biotech announced that it would discontinue efforts to develop Voxzogo for children with Noonan syndrome, a genetic growth disorder that can affect height, facial features and the heart.

In a deal that allows Sanofi to…

September 15th, 2026|Fierce Pharma|

In a deal that allows Sanofi to shed assets wrapped up in mature products, German drugmaker Cheplapharm will take over 20 medicines and three manufacturing sites from Sanofi. In exchange, Sanofi is picking up a

AbbVie has partnered with the PGA…

September 15th, 2026|Fierce Pharma|

AbbVie has partnered with the PGA Tour and the 2026 Presidents Cup, teeing up the “Birdies for Brain Health” initiative to funnel cash to six patient advocacy organizations.

The FDA has approved the…

September 15th, 2026|Fierce Pharma|

The FDA has approved the industry’s first radioligand equivalent in Curium’s lutetium Lu 177 dotatate injection, Bexlutry, after a court cleared the Boston company of all patent claims brought by Novartis.

Lindsey Vonn knows more than most…

September 15th, 2026|Fierce Pharma|

Lindsey Vonn knows more than most about pain. Spending years training as an elite alpine ski racer puts enough pressure on your body, but Vonn’s injuries and her major crash earlier this year that nearly

Shionogi is stepping up promotion…

September 14th, 2026|Fierce Pharma|

Shionogi is stepping up promotion of COVID-19 drug Xocova, working with The Bloc on an omnichannel campaign designed to encourage people to contact their healthcare professional after being exposed to the virus.